Skip to main content
SpringerLink
Log in

Independent prognostic factors in endometrial cancer: a single institution review

  • Research Article
  • Published:
Central European Journal of Medicine

Abstract

The purpose of this study was to conduct a clinical and pathologic review of endometrial cancers diagnosed and surgically treated in our institution to evaluate results of treatment in relation to current international recommendations. We retrospectively evaluated the clinical history, treatment and follow-up of patients with histologically confirmed endometrial cancer treated in Faculty Hospital Nitra, Slovakia from 1990 to 2005. Data were abstracted regarding tumor histology, grade, age, parity, stage, diabetes, use of oral contraceptives, BMI, survival and treatment modalities including surgery, radiation therapy, chemotherapy, hormonal therapy, and combinations thereof. One hundred and thirty nine patients received surgical treatment for endometrial cancer: stage I -101 (72,6%), stage II - 9 (6,5%), stage III - 23 (16,6%) and stage IV - 6 (4,3%). Tumors were well differentiated in 87(62,6%), moderately differentiated in 32 (23%) and poorly differentiated in 20 (14,4%). There were 45 (32,4%) premenopausal patients and 94 (67,6%) postmenopausal. In multivariate statistical analysis we identified FIGO stage, tumor type, tumor grade, nodal status and depth of myometrial invasion as independent prognostic factors for overall survival, and FIGO stage, nodal status, and tumor grade as independent prognostic factors for recurrence-free interval.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Uharcek P, Mlyncek M, Ravinger J. Surgical management of endometrial cancer in Slovak Republic. Eur J Surg Oncol 2006;32(1):94–7

    Article  PubMed  CAS  Google Scholar 

  2. Shepherd JH. Revised FIGO staging for gynaecological cancer. Brit J Obstet Gynaec 1989;96:889–92

    Article  PubMed  CAS  Google Scholar 

  3. Boronow RC, Morrow CP, Creasman WT. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63:825–32

    PubMed  CAS  Google Scholar 

  4. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer (a GOG study). Cancer 1987;60:2035–41

    Article  PubMed  CAS  Google Scholar 

  5. Barakat RR, Park RC, Grigsby PW, Muss HD, Norris HJ. Corpus: epithelial tumors. In: Hoskins WJ, Perez CA, Young RC, (eds). Principles and practice of gynecologic oncology. ed 2. Philadelphia: Lippincott-Raven Publishers, 1997: 859–896

    Google Scholar 

  6. Morrow CP, Bundy BN, Kurman, RJ, et al.: Relationship between surgical-pathologic risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol. Oncol. 1991; 40: 55–65

    Article  PubMed  CAS  Google Scholar 

  7. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–104

    Article  PubMed  Google Scholar 

  8. Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol. 2004;35:649–662

    Article  PubMed  Google Scholar 

  9. Mammoliti S, Bruzzone M, Chiara S. Clinical stage I and II endometrial carcinoma: multivariate analysis of prognostic factors. Anticancer Res 1992;12:1415–1418

    PubMed  CAS  Google Scholar 

  10. Ju W, Myung SK, Kim Y, Choi HJ, Kim SC.: Comparison of laparoscopy and laparotomy for management of endometrial carcinoma: a meta-analysis. Int J Gynecol Cancer 2009;19(3):400–406

    Article  PubMed  Google Scholar 

  11. Gambrell RD, Bagnell CA, Greenblatt RB. Role of estrogens and progesterone in etiology and prevention of endometrial cancer: review. Am J Obstet Gynecol 1983; 15:696–707

    Google Scholar 

  12. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625–1638

    Article  PubMed  Google Scholar 

  13. Eifel PJ, Ross J, Hendrickson M, Cox RS, Kempson R, Martinez A. Adenocarcinoma of the endometrium. Cancer 1983;52:1026–1031

    Article  PubMed  CAS  Google Scholar 

  14. Steiner E, Eicher O, Sagemüller J, Schmidt M, Pilch H, Tanner B, Hengstler JG, Hofmann M, Knapstein PG. Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer. 2003;13(2):197–203

    Article  PubMed  CAS  Google Scholar 

  15. Tabernero LM, Alonso MC, Ojeda B et al. Endometrial cancer stages I and II. Eur J Gynecol Oncol 1995;16:18–25

    CAS  Google Scholar 

  16. Ayhan A, Tuncer R, Tuncer Z, Yuce K, Kucukali T. Correlation between clinical and histopathologic risk factors and lymph node metastases in early endometrial cancer (a multivariate analysis of 183 cases) International Journal of Gynecologic Cancer 1994;4: 306–309

    Article  Google Scholar 

  17. ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373(9658):125–136

    Article  PubMed  CAS  Google Scholar 

  18. Corn BW, Lanciano RM, D’agostino R, Kiggundu E, Dunton CJ, Purser P, et al. The relationship of local and distant failure from endometrial cancer: defining a clinical paradigm. Gynecol Oncol 1997;66:411–416

    Article  PubMed  CAS  Google Scholar 

  19. Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC. Endometrial cancer: predictors of peritoneal failure. Gynecol Oncol 2003;89:236–242

    Article  PubMed  Google Scholar 

  20. Kuoppala T, Mäenpää J, Tomas E, Puistola U, Salmi T, Grenman S, et al. Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemoradiotherapy. Gynecol Oncol 2008;110:190–195

    Article  PubMed  Google Scholar 

  21. Fujimoto T, Nanjyo H, Fukuda J, Nakamura A, Mizunuma H, Yaegashi N, Sugiyama T, Kurachi H, Sato A, Tanaka T. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence. Gynecol Oncol. 2009;112(2):342–347

    Article  PubMed  Google Scholar 

  22. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, et al. Therapeutic role of lymph node resection in endometrial corpus cancer. Cancer 2006;107:1823–1830

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Faculty Hospital Nitra, 949 01, Nitra, Slovakia

    P. Uharček, M. Mlynček, J. Ravinger, E. Lajtman & M. Matejka

Authors
  1. P. Uharček
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Mlynček
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Ravinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Lajtman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Matejka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Uharček.

About this article

Cite this article

Uharček, P., Mlynček, M., Ravinger, J. et al. Independent prognostic factors in endometrial cancer: a single institution review. cent.eur.j.med 6, 294–299 (2011). https://doi.org/10.2478/s11536-011-0007-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-011-0007-3

Keywords

Search

Navigation